Straumann Group Announces Mid-Term Growth Strategy

Straumann Group has unveiled a new growth strategy aimed at increasing market share, strengthening profitability, and enhancing cash generation by 2030. Building on strong progress since 2021, the company reported a 16.2% CAGR in organic revenue growth and a 32.4% core EBIT margin at constant FX. The strategy leverages innovative digital workflows through the Straumann AXS platform to streamline dental treatments.

The Group plans to expand its market presence in implantology and orthodontics while advancing prosthetic digital workflows. Financial goals include achieving 10% CAGR in revenue growth and improving profitability by 40 to 50 basis points annually from 2026 to 2030.

Straumann's focus on its digital ecosystem and high-performance company culture aims to translate this growth into increased cash flow, supporting ongoing innovation and shareholder returns.